Christopher R. Cline
CHIEF FINANCIAL OFFICER · 6 filings · Latest: Sep 15, 2026
Travere Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | CHRISTOPHER CLINE | — | Dec 1, 2025 | Proposed Sale | $35.01 | 20,000 | $700.2K | — | |
TVTX | Christopher Cline | — | May 5, 2025 | Proposed Sale | $21.05 | 1,784 | $37.6K | — | |
TVTX | Christopher Cline | — | Apr 11, 2025 | Proposed Sale | $13.14 | 48 | $631 | — | |
TVTX | Christopher Cline | — | Feb 3, 2025 | Proposed Sale | $20.12 | 5,192 | $104.5K | — |
← Previous
Page 2 of 2